Wintermute Biomedical News
Wintermute Biomedical began with a decade of medical research to find solutions to drug resistant infections.
Novel inhalation therapy moves to animal trials in US $3 Billion fast-track COVID-19 treatments program under Dr Anthony Fauci.
